Date published: 2025-12-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr413 Inhibitors

Olr413 inhibitors are a class of chemical compounds that interact specifically with the olfactory receptor 413 (Olr413), a G protein-coupled receptor (GPCR) predominantly found in olfactory tissues. These inhibitors are designed to bind to the Olr413 receptor, modulating its activity by either preventing or altering the receptor's ability to detect or respond to certain odorant molecules. The molecular interactions between Olr413 inhibitors and the receptor are typically characterized by high specificity and affinity, which are crucial for achieving precise modulation of the receptor's function. This specificity is often achieved through intricate molecular designs that allow these inhibitors to fit snugly within the binding pocket of Olr413, effectively blocking or altering its normal conformation and signaling pathways. The study of Olr413 inhibitors has gained interest in chemical biology due to their potential to reveal insights into the fundamental mechanisms of olfactory perception and the broader roles of GPCRs in sensory processes.

Structurally, Olr413 inhibitors are diverse, ranging from small organic molecules to more complex synthetic compounds. The design and synthesis of these inhibitors often involve extensive computational modeling and structure-activity relationship (SAR) studies to optimize their interaction with the Olr413 receptor. Chemical modifications are typically employed to enhance the stability, bioavailability, and selectivity of these inhibitors, making them valuable tools in studying receptor dynamics. The ability to precisely control Olr413 activity using these inhibitors provides researchers with the means to dissect the receptor's role in olfaction and to explore how modifications in receptor function can influence olfactory signaling pathways. The chemical exploration of Olr413 inhibitors also contributes to a broader understanding of GPCR modulation, potentially influencing future research in receptor biology and sensory systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$73.00
$163.00
2
(1)

Calcium channel blocker, can indirectly affect GPCR signaling by altering calcium dynamics, potentially impacting Olr413.

Bosentan

147536-97-8sc-210957
10 mg
$191.00
3
(1)

Endothelin receptor antagonist, might influence GPCR signaling indirectly through endothelin pathways, impacting Olr413.

Clopidogrel

113665-84-2sc-507403
1 g
$120.00
1
(0)

Platelet aggregation inhibitor, could modulate GPCR signaling indirectly through platelet function, impacting Olr413.

Eplerenone

107724-20-9sc-203943
sc-203943A
10 mg
50 mg
$108.00
$612.00
4
(1)

Aldosterone antagonist, can influence GPCR signaling indirectly through mineralocorticoid pathways, impacting Olr413.

Ivabradine hydrochloride

148849-67-6sc-507513
10 mg
$120.00
(0)

If channel inhibitor, might modulate GPCR signaling indirectly through cardiac electrophysiological effects, impacting Olr413.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Angiotensin II receptor blocker, could indirectly affect GPCR signaling, potentially impacting Olr413.

Prasugrel

150322-43-3sc-391536
100 mg
$77.00
(0)

Antiplatelet drug, may affect GPCR signaling indirectly through inhibition of platelet aggregation, impacting Olr413.

Rivaroxaban

366789-02-8sc-208311
2 mg
$155.00
18
(1)

Anticoagulant, can modulate GPCR signaling indirectly through coagulation pathway effects, impacting Olr413.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$71.00
$92.00
8
(1)

Angiotensin II receptor blocker, might indirectly influence GPCR signaling, potentially impacting Olr413.

Valsartan

137862-53-4sc-220362
sc-220362A
sc-220362B
10 mg
100 mg
1 g
$39.00
$90.00
$120.00
4
(1)

Angiotensin II receptor antagonist, could alter GPCR signaling indirectly, potentially impacting Olr413.